Conexeu Sciences Inc CNXU

US Biotechnology
$8.31 β–Ό -5.89% ($-0.52)
Open $8.89
Prev Close $8.83
Day Range $8.26 – $8.99
52W Range $7.10 – $18.79
Market Cap $222.36M
Beta -3.26

πŸ“‹ Company Profile

IndustryBiotechnology
CountryUS
ExchangeNASDAQ NMS - GLOBAL MARKET
CurrencyUSD
IPO Date2026-05-21
Shares Out.26,760,000
Websiteconexeu.com β†—
Phone7025138856
About Conexeu Sciences Inc

Conexeu Sciences Inc is an early-stage medical technology company. The company develops and supplies collagen-based technologies that helps doctors and patients regenerate tissue naturally, safely, and effectively. The company is focused on developing regenerative biomaterials that address relative needs in wound care, dentistry, and aesthetics. The company seek to provide physicians with device-based solutions that improve healing, restore soft tissue, and enhance patient outcomes across multiple clinical settings. The company focuses durable, and growing addressable markets in regenerative aesthetics, wound care, 3D-printed tissue structures, veterinary wound repair, and dental soft-tissue regeneration.

Conexeu Sciences Inc is a publicly traded company under the ticker symbol CNXU on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.

πŸ‘₯ Related Stocks